ArticleBiology direct2025

Prognostic model integrating histology, systemic inflammation, and recurrence status predicts immunotherapy response in advanced non-small-cell lung cancer patients.

F V Moiseenko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.